News – Page 544 – Endpoints News

Thousands of layoffs planned as part of Novartis restructuring — report

4 years ago

As FDA lifts clinical hold on its $4.9B CD47 drug, Gilead talks 2023 readout, 'unwavering' confidence

4 years ago

Novartis jumps into the KRAS race with a positive early snapshot — and a full slate of trials planned for ambitious ...

4 years ago

FDA quietly chats with states on drug import plans — signaling Biden isn't ready to dispense with Trump's idea

4 years ago

Federal appeals court overturns $137M patent verdict against Roche — but the case isn't closed just yet

4 years ago

Amgen rejuvenates Enbrel ad campaign as biosimilars remain sidelined

4 years ago

Pharma firms make new pledge to launch in all Euro markets at least 2 years post-authorization

4 years ago

Ballooning 340B market reaches almost 15% of 2021 US pharma sales, IQVIA finds

4 years ago

Texas jury awards Seagen nearly $42M in Enhertu patent case

4 years ago

Hours after Pfizer, Moderna names its own new CFO with dental, healthcare and auto chops

4 years ago

Pfizer's Albert Bourla turns to an accomplished dealmaker, strategy expert for its next CFO

4 years ago

Vanda takes FDA to court again, this time seeking more info on a rejection letter

4 years ago

AACR22: Bristol Myers' Opdivo is yet to reach survival endpoint in early-stage lung cancer. But will it matter?

4 years ago

Merck extends pact with NK cell specialists at Artiva; Regeneron-allied biotech pencils in $15M IPO

4 years ago

Covid-19 roundup: Gavi raises $4.8B in pledged funds; Japan cancels order of 40M remaining AstraZeneca shots

4 years ago

Patient death triggers a second clinical hold for Curis as FDA seeks more data

4 years ago

Germany deal with CureVac and GSK primed for 80M mRNA vaccines a year

4 years ago

J&J takes Crohn's med Stelara in new direction, with bolder and brighter outlook

4 years ago

Eli Lilly fleshes out more PhIII data for Dupixent challenger as AD rivalry heats up

4 years ago

The one early biotech bright spot at #AACR22 just turned red

4 years ago

BioNTech to explore potential of delivering mRNA vaccines orally with new partner

4 years ago

Stealth UK biotech in-licenses Lilly candidates in pursuit of 'inhibiting the inhibitor' in cardiovascular disease

4 years ago

‘Don’t want to fuss with this stuff’: Another DNA synthesis startup reels in funding

4 years ago

Can a withdrawn Eli Lilly drug find second life in radiopharma? Little biotech hands over $5M cash to find out

4 years ago

First page Previous page 541 542 543544545 546 547 Next page Last page